Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07691112 · ClinicalTrials.gov registry record
Prevalence of Chapman Reflex Points in Medical Students and Their Association With Visceral Symptoms
A clinical trial, sponsored by The Touro College and University System.
- Completed
- Registry status
- 101
- Enrollment target
NCT07691112 is a clinical trial that has completed, run by The Touro College and University System. The registered enrollment target is 101 participants.
The verdict
NCT07691112 has completed, sponsored by The Touro College and University System.
- COMPLETED
- Registry status
- 101 participants
- Enrollment target
Study Summary
Chapman Reflex Points (CRPs) are small palpable nodules found within connective tissue that have traditionally been associated with dysfunction of internal organs and the autonomic nervous system. However, little is known about how commonly these findings occur in healthy individuals or whether they are associated with symptoms experienced by otherwise healthy people. The purpose of this study is to determine the prevalence of Chapman Reflex Points in young healthy adults and to evaluate whether the presence and distribution of these points are associated with self-reported visceral symptoms. Participants complete a standardized health questionnaire regarding recent and recurrent symptoms and undergo a blinded physical examination of established Chapman Reflex Point locations performed by a trained investigator. The results of this study may improve understanding of the physiological mechanisms underlying Chapman Reflex Points and help clarify their potential role in preventive osteopathic assessment and early identification of altered autonomic, lymphatic, fascial, or neuroendocrine function.
Interventions
- PROCEDURE Chapman Reflex Point Examination
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 101 participants |
| Start Date | 2020-03-04 |
| Est. Completion | 2026-06-27 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07691112
The ClinicalTrials.gov registry entry for NCT07691112 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 101 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Touro College and University System, which has 7 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chapman Reflex Point Examination is the first listed.
NCT07691112 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07691112 about?
NCT07691112 is a clinical study titled "Prevalence of Chapman Reflex Points in Medical Students and Their Association With Visceral Symptoms". Chapman Reflex Points (CRPs) are small palpable nodules found within connective tissue that have traditionally been associated with dysfunction of internal organs and the autonomic nervous system. However, little is known about how commonly these findings occur in healthy individuals or whether they...
What is the current status of trial NCT07691112?
This trial is currently completed. The enrollment target is 101 participants. The study started on 2020-03-04. Estimated completion is 2026-06-27.
What interventions are being tested in trial NCT07691112?
The interventions under investigation include: Chapman Reflex Point Examination (PROCEDURE).
Who is sponsoring clinical trial NCT07691112?
This trial is sponsored by The Touro College and University System, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.